(Press-News.org) Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) demonstrated for the first time that treatment-naive patients with early Rheumatoid Arthritis (RA) have myocardial and vascular abnormalities, even at the earliest stage of their disease. These findings suggest that patients may develop early cardiomyopathy (disease of the heart muscle), increasing their risk of cardiovascular morbidity and mortality from the time of their diagnosis. Cardiomyopathy is a serious condition and a leading cause of hospitalisation worldwide.
Patients with RA have an excess risk of heart failure and associated mortality compared with the general population. Previous cardiac studies of patients with established RA have demonstrated left ventricular (LV) abnormalities associated with the development of heart failure and CV morbidity and mortality. This is the first study to use cardiac MRI to identify the presence of changes in myocardial and vascular function in treatment-naïve early RA.
"We've seen that, even in patients with early RA, changes suggestive of cardiomyopathy are evident, including reduced vascular function, ventricular volumes, and a trend towards a change in LV geometry," said senior author Dr. Maya Buch of the Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds. "Further investigation will now be required to clarify the natural history of these changes, their clinical implications, and most importantly the scope to modify CV outcomes with effective RA therapy," she added.
EULAR guidelines recommend that the increased CV risk for RA patients is managed by involving a cardiovascular specialist, and with aggressive suppression of the inflammatory process using one or more DMARDs .
66 patients with treatment-naïve early RA fulfilling ACR /EULAR classification criteria and with no previous history of CV disease underwent cardiac MRI. All patients had experienced RA symptoms for less than 1 year, were DMARD treatment-naïve, and had a minimum disease activity score (DAS28 ) of at least 3.2. Thirty healthy controls were matched by age, sex and blood pressure for comparison.
Aortic stiffness is considered to be an independent predictor of cardiovascular mortality and is measured by aortic distensibility, the ability of the artery to expand. Distensibility was significantly reduced in the early RA patients compared to healthy controls (p=0.001), with other measures of arterial stiffness showing similar significant differences. Left ventricular and right ventricular end-systolic and end-diastolic volumes were all significantly lower in the group of early RA patients vs. healthy controls.
INFORMATION:
Abstract Number: OP0163
NOTES TO EDITORS:
For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress Press Office in Room 5B of Fiera Roma during EULAR 2015 or on:
Email: eularpressoffice@cohnwolfe.com
Onsite tel: +44 (0) 7738 890 799/ +44 (0) 20 7331 5442
Twitter: @EULAR_Press
Youtube: Eular Pressoffice
About EULAR
The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with rheumatic diseases throughout Europe.
EULAR aims to promote, stimulate and support the research, prevention, and treatment of rheumatic diseases and the rehabilitation of those it affects.
With 45 scientific member societies, 35 People with Arthritis and Rheumatism in Europe (PARE) organisations, 19 health professionals associations and 21 corporate members, EULAR highlights the importance of combating rheumatic diseases through both medical means and patient care.
EULAR 2015 is set to be the biggest rheumatology event in Europe with around 14,000 scientists, physicians, allied health professionals and related audiences in attendance from more than 120 countries. Over the course of the congress there will be some 300 oral and just under 2,000 poster abstract presentations, more than 150 sessions, 400 lectures, 40 poster tours and 350 invited speakers.
To find out more about the activities of EULAR, visit: http://www.eular.org
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) identified that the cytokine (cell signalling protein) Interleukin-1β (IL-1β) is a crucial factor in the development of blood-induced cartilage damage. This finding opens up the possibility that a treatment targeting IL-1β could provide a new way to protect cartilage after a joint bleed, which in turn should significantly reduce subsequent disability.1
Exposure of joint cartilage to blood can occur after joint trauma, ...
Rome, Italy, 12 June 2015: Two new studies presented at the European League Against Rheumatism Annual Congress (EULAR 2015) have shown the importance of using ultrasound to identify those Rheumatoid Arthritis (RA) patients in clinical remission who would benefit from more intensive treatment.
Many patients deemed to be in clinical remission still have active joint disease without any obvious symptoms or physical signs, but with risk of further progression of joint damage. Using ultrasound to predict the risk of flare and exacerbation of symptoms will allow these patients ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference showed that the chickenpox (varicella) vaccine can be effective and safe even in children with paediatric rheumatic disease receiving immunosuppression treatment. By using a checklist to pre-screen children, the investigators were able to identify diverse patient groups suitable for vaccination, protecting them from a potentially life-threatening infection.
Rheumatic diseases are autoimmune diseases, arising when the ...
Rome, Italy, 12 June 2015: Three new studies presented at the European League Against Rheumatism Annual Congress (EULAR 2015) have provided valuable guidance on measuring fatigue and optimising its treatment in Rheumatoid Arthritis (RA) patients, and in patients with other rheumatic diseases. Fatigue remains a frequent and debilitating problem for patients with RA that needs to be addressed.
Findings from these studies show:
Chronic fatigue in RA patients has been identified as not being well managed by healthcare professionals, with 79% claiming their fatigue had ...
Rome, Italy, 12 June 2015: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) Press Conference revealed that DNA methylation - a mechanism that regulates gene expression - could influence the progression of structural damage to the joints and spine in ankylosing spondylitis (AS). Study findings showed significant associations between a low methylation score and more radiographic progression (X-ray) of the disease, and implicated smoking in worsening of disease outcome.
DNA methylation is one of several epigenetic ...
Older patients with asthma are at increased risk for treatment failure, particularly those patients being treated with inhaled corticosteroids, according to a new study.
"Asthma morbidity and mortality are known to be increased in middle-aged and older patients, and gender may also affect the incidence and course of the disease, but the impact of age and gender on asthma treatment response is not well understood," said study author Michael E. Wechsler, MD, MMSc, professor of medicine and director of the Asthma Program at National Jewish Health in Denver. "In our study ...
The new threshold for diabetes in pregnancy recently introduced by the UK's National Institute for Health and Care Excellence (NICE) misses a significant number of women at risk of serious complications, a report published today in the Diabetologia (the journal of the European Association for the Study of Diabetes) shows.
A team of researchers from the University of Cambridge and Cambridge University Hospitals Foundation Trust have discovered that the proposed new NICE thresholds are less effective than international thresholds set by World Health Organization (WHO) at ...
Among children with chronic kidney disease, those with lower vitamin D levels had higher levels of blood markers related to kidney dysfunction as well as greater kidney function loss over time.
Five-year kidney survival was 75% in patients with vitamin D levels 50 nMol/L at the start of the study and 50% in those with lower levels.
There is a high prevalence of vitamin D deficiency in children with chronic kidney disease.
Washington, DC (June 11, 2015) -- Maintaining normal vitamin D levels helps preserve kidney function in children with chronic kidney disease (CKD), ...
WASHINGTON -- Messages with images depicting the harsh realities of melanoma are more powerful than the text-only warning required by the U.S. Food and Drug Administration in persuading women to reconsider indoor tanning. This is according to a new study by Georgetown Lombardi Comprehensive Cancer Center researchers.
The study, published in the American Journal of Public Health, is the first to examine use of persuasive messaging and graphic imagery for indoor tanning device warnings -- the source of thousands of skin cancer cases, including melanoma, each year.
"In ...
DALLAS, June 11 -- Intense education can help stroke survivors quickly recognize symptoms of a subsequent stroke and seek prompt treatment, according to a study in Stroke, journal of the American Heart Association.
Few stroke patients arrive at an emergency department within three hours of symptom onset. The U.S. FDA has approved the clot-busting drug tissue plasminogen activator, or tPA, to be given within three hours of symptom onset, while the American Heart Association/ American Stroke Association suggest it can be given up to 4.5 hours in some patients.
A study ...
